Member Login

RCBC| Life sciences, healthcare, and telemedicine Working group

  • 27 Oct 2021
  • 11:00 AM - 12:30 PM
  • Virtual event
  • 75



Date: Wednesday, October 27, 2021

Time: 11 am Ottawa, 6 pm Moscow 

Subsectors: pharmaceuticals, biopharmaceuticals, oncology, infectious diseases, imaging and medical devices, life science, healthcare technologies, telemedicine, etc

  • Canadian healthcare industry

Canada represents the 10th largest market in the world for pharmaceutical sales. It is Canada’s infrastructure, talent and access to inclusion in global supply chains that help draw the world’s largest life sciences companies conducting research, running clinical trials and manufacturing new drugs. 

With hot spots for cancer research, radiation therapies, regenerative treatments, brain and vascular health from coast to coast, multinational organizations recognize that life-changing advancements in patient care are happening in Canada. Innovative lifesaving treatment protocols, pharmaceutical drug therapies and medical devices developed in Canada contribute to the place of the country as a world leader in health sciences. Canada’s leadership in digital technology, robotics and AI is helping to change patient care through future-focused advancements in everything from medtech to medical manufacturing.

  • Healthcare industry of Russia
The pharmaceutical industry, which involves the development, production, and marketing of medications, is  expanding in Russia and  is projected to grow to 2.35 T Russian rubles by 2023. One of the factors shaping the market is the government's push for national security in medicine supply, outlined in the document "Pharma 2030 Strategy." The industry is dependent on import trade, valued at nearly 334 B Russian rubles in the first half of 2020 (wide range of medical equipment, including dental sector). Another driving force of the industry is the evolution of online retail of medicines, legalized during the COVID-19 pandemic. In 2020, the pharma e-commerce market in Russia reached 131 B Russian rubles.

Taking into account the current market trends, there are four main ways of doing business with Russia:

  • cooperation with the Russian distributors
  • localization of production (construction of all necessary infrastructure from scratch/ cooperation with the Russian manufacturer/transfer of technologies)
  • joining medical and pharmaceutical clusters
  • buying/acquiring an already existing business on the territory of Russia
We will specifically cover the countries’ regulation, intellectual property and the ability to protect it; the education of and availability of an expert workforce; infrastructure and the countries' R&D programs.

A G E N D A 

Moderator: Paul Jones, Principal, Law firm Jones and Co.


Stanislav Naumov, Chairman of the Board of the Association of Pharmaceutical Manufacturers EAEU Countries 

Paul Jones, Principal, Law firm Jones and Co.

11:00 - Welcoming remarks  

Stanislav Naumov, Chairman of the Board of the Association of Pharmaceutical Manufacturers EAEU Countries 

Paul Jones, Principal, Law firm Jones and Co.

11:10 – 12:30 Discussions

Session on Russia:

Success stories of Eurasian pharmaceutical companies. Regulation of the circulation of medicines on the EAEU market. Stanislav Naumov, Chairman of the Board of the Association of Pharmaceutical Manufacturers EAEU Countries 

Entering the pharmaceutical market of Russia: steps, strategies and pitfalls. Oleg Berezin, Partner, Tax&Legal, Deloitte Russia

Certification of pharmaceutical products and medical devices in Russia. The Ministry of Industry and Trade of Russia (tbc)

Protection of pharmaceutical products and medical devices in Russia. Paul Jones, Principal, Law firm Jones and Co.

Privacy issues, enscryption, internet coverage and speed connections across Russia (tbc)

Session on Canada:

North American patent landscape and portfolio management best practices.Tuba Yamaç, Ph. D., Partner, Patent Agent, BCF

Canadian healthcare system and Health Canada requirements for medical devices manufacturersAaron Burke, Director of Marketing, MedCare Medical Devices Canada. Eugene Pik, CEO, MedCare Medical Devices Canada

Quebec life sciences and health tech sectors: strengths, achievements and investment incentives. Nadia Dube, Senior Project Director, Life Sciences and Health Technologies, Invest Quebec 

Success stories of development, production, registration of medicinal products in Canada. (tbc)

11:55 - Closing remarks

Stanislav Naumov, Chairman of the Board of the Association of Pharmaceutical Manufacturers EAEU Countries 

Paul Jones, Principal, Law firm Jones and Co.

Observers: Dmitry Rozhdestvenskiy, Head of Section of Coordination of Activities in the Sphere of Circulation of Medicines and Medical Products, Technical Regulation and Accreditation Department, Eurasian Economic Commission 

Dariya Demidovich, Lawyer and chief consultant of the Association of Pharmaceutical Manufacturers EAEU Countries 


Each and every participant is invited to present his/her projects in the peer learning platform BRAINDATE. 

What’s in it for you?

  • Establish contacts with Canadian and Russia entities in the life sciences, healthcare and telemedicine industries
  • Get prepared to export or import
  • Attract financing
  • Find partners in Canada or Russia
  • Invest in Canada or Russia
  • Get a job in the field of life sciences, healthcare and telemedicine


The Canada-Russia Business Council was established in December 2004 as a joint venture between CERBA and the Russian Union of Industrialists and Entrepreneurs (RSPP) on the basis of a proposal agreed between then-Canadian Prime Minister Paul Martin and Russian President Vladimir Putin.  Over its 17 years of existence, the CRBC has become a crucial vehicle for promotion and support of bilateral cooperation between Russia and Canada.


We are offering an exceptional opportunity to obtain additional visibility and opportunities to promote your services through the Business Council, CERBA Podcast and RCBC Awards by becoming a sponsor of this event.

RCBC Sponsorship Packages

To make the event a success, register today and together with CERBA and your RD get involved in the preparation process much in advance.

For  more information, partnership, and sponsorship, please, contact

 Marina Belskikh, Regional Director of CERBA in Montreal and Ottawa, 

via email [email protected] or tel. +1  (514) 5161178


Alex Grichine, Regional Director of CERBA in Moscow

via emai[email protected] or tel. +7 (495) 134-0268.